The Evolutionary Analysis of Emerging Low Frequency HIV-1 CXCR4 Using Variants through Time—An Ultra-Deep Approach
暂无分享,去创建一个
David L. Robertson | Marilyn Lewis | Andrew Rambaut | John P. Archer | P. Richard Harrigan | Bruce E. Taillon | B. Taillon | P. Harrigan | J. Archer | A. Rambaut | D. Robertson | Sergei L. Kosakovsky | M. Lewis
[1] Hanlee P. Ji,et al. Next-generation DNA sequencing , 2008, Nature Biotechnology.
[2] David A. Price,et al. Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity , 2005, Antimicrobial Agents and Chemotherapy.
[3] G. Crooks,et al. WebLogo: a sequence logo generator. , 2004, Genome research.
[4] R. Connor,et al. Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals , 1997, The Journal of experimental medicine.
[5] Hans Wolf,et al. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS , 1986, Cell.
[6] Michael Brudno,et al. SHRiMP: Accurate Mapping of Short Color-space Reads , 2009, PLoS Comput. Biol..
[7] David L. Robertson,et al. Human immunodeficiency virus: Phylogeny and the origin of HIV-1 , 2001, Nature.
[8] P. Narciso,et al. Use of massive parallel pyrosequencing for near full-length characterization of a unique HIV Type 1 BF recombinant associated with a fatal primary infection. , 2009, AIDS research and human retroviruses.
[9] S. Zolla-Pazner,et al. Structural basis for coreceptor selectivity by the HIV type 1 V3 loop. , 2007, AIDS research and human retroviruses.
[10] M. Ronaghi,et al. Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. , 2007, Genome research.
[11] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.
[12] James R. Knight,et al. Genome sequencing in microfabricated high-density picolitre reactors , 2005, Nature.
[13] S. Nelson,et al. BFAST: An Alignment Tool for Large Scale Genome Resequencing , 2009, PloS one.
[14] Giovanni Chillemi,et al. Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations , 2009, Retrovirology.
[15] Andrew J. Low,et al. Improved Detection of CXCR4-Using HIV by V3 Genotyping: Application of Population-Based and “Deep” Sequencing to Plasma RNA and Proviral DNA , 2010, Journal of acquired immune deficiency syndromes.
[16] David L. Robertson,et al. CTree: comparison of clusters between phylogenetic trees made easy , 2007, Bioinform..
[17] Michal Sharon,et al. Molecular switch for alternative conformations of the HIV-1 V3 region: Implications for phenotype conversion , 2006, Proceedings of the National Academy of Sciences.
[18] S. Salzberg,et al. Bioinformatics challenges of new sequencing technology. , 2008, Trends in genetics : TIG.
[19] Robert C. Edgar,et al. MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.
[20] Jeremy Buhler,et al. Efficient large-scale sequence comparison by locality-sensitive hashing , 2001, Bioinform..
[21] M S Waterman,et al. Identification of common molecular subsequences. , 1981, Journal of molecular biology.
[22] J. Albert,et al. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype , 1997, Journal of virology.
[23] Mike Youle,et al. Emergence of CXCR4-Using Human Immunodeficiency Virus Type 1 (HIV-1) Variants in a Minority of HIV-1-Infected Patients following Treatment with the CCR5 Antagonist Maraviroc Is from a Pretreatment CXCR4-Using Virus Reservoir , 2006, Journal of Virology.
[24] Cole Trapnell,et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.
[25]
R. Durbin,et al.
Mapping Quality Scores Mapping Short Dna Sequencing Reads and Calling Variants Using P ,
2022
.
[26]
A. Jetzt,et al.
High Rate of Recombination throughout the Human Immunodeficiency Virus Type 1 Genome
,
2000,
Journal of Virology.
[27]
O. Gascuel,et al.
A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood.
,
2003,
Systematic biology.
[28]
James Theiler,et al.
Quantitative Deep Sequencing Reveals Dynamic HIV-1 Escape and Large Population Shifts during CCR5 Antagonist Therapy In Vivo
,
2009,
PloS one.
[29]
H. Schuitemaker,et al.
Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis.
,
1999,
The Journal of infectious diseases.
[30]
D. Cooper,et al.
Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection.
,
2010,
The Journal of infectious diseases.
[31]
E. Tramont,et al.
The human immunodeficiency virus.
,
1991,
Dermatologic clinics.
[32]
M. Malim,et al.
HIV-1 Sequence Variation Drift, Shift, and Attenuation
,
2001,
Cell.
[33]
C. Nusbaum,et al.
Quality scores and SNP detection in sequencing-by-synthesis systems.
,
2008,
Genome research.
[34]
John W. Mellors,et al.
Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis
,
2005,
Journal of Clinical Microbiology.
[35]
J. Margolick,et al.
Improved Coreceptor Usage Prediction and GenotypicMonitoring of R5-to-X4 Transition by Motif Analysis of HumanImmunodeficiency Virus Type 1 env V3 LoopSequences
,
2003,
Journal of Virology.
[36]
V. Calvez,et al.
When and how to use maraviroc in HIV-infected patients
,
2009,
AIDS.
[37]
John Archer,et al.
Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencing
,
2009,
AIDS.
[38]
W. J. Kent,et al.
BLAT--the BLAST-like alignment tool.
,
2002,
Genome research.
[39]
O. Gascuel,et al.
Approximate likelihood-ratio test for branches: A fast, accurate, and powerful alternative.
,
2006,
Systematic biology.
[40]
Kevin Dieckhaus,et al.
Low-Abundance HIV Drug-Resistant Viral Variants in Treatment-Experienced Persons Correlate with Historical Antiretroviral Use
,
2009,
PloS one.
[41]
B. Korber,et al.
Evolutionary and immunological implications of contemporary HIV-1 variation.
,
2001,
British medical bulletin.
[42]
John Archer,et al.
Understanding the diversification of HIV-1 groups M and O
,
2007,
AIDS.